The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...

Pfizer faces growth challenges with patent losses and waning COVID sales. Selling an ATM Put option expiring Nov'25 could ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services ...

Officials say the Army has reenlisted more than 23 soldiers who were discharged for refusing the COVID-19 vaccine.

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay.

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new pandemic surged around them. By a year later, 66 million American adults had ...

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

These five well-known dividend stocks were beaten down in the recent selling but will remain attractive long after the tariff ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...